Publications by authors named "Tian-Wei Fu"
Article Synopsis
- In China, two methods for improving liver function before surgery, PALPP and TACE plus PVE, have been used but not compared for effectiveness.
- A study analyzed the clinical outcomes of 29 patients, revealing no significant differences in complications but highlighting that PALPP led to faster growth in liver volume.
- PALPP not only achieved a higher rate of successful two-stage surgeries but also resulted in greater FLR volume increases without adding extra risks compared to TACE plus PVE.
Background: The Naples Prognostic Score (NPS), integrating inflammatory and nutritional biomarkers, has been reported to be associated with the prognosis of various malignancies, but there is no report on intrahepatic cholangiocarcinoma (ICC). This study aimed to explore the prognostic value of NPS in patients with ICC.
Methods: Patients with ICC after hepatectomy were collected, and divided into three groups.
Background: Postoperative complications are vital factors affecting the prognosis of patients with hepatocellular carcinoma (HCC), especially for complex hepatectomy. The present study aimed to compare perioperative complications between laparoscopic and robotic complex hepatectomy (LCH vs. RCH).
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the impact of a three-dimensional (3D) printed dry-laboratory model on planning laparoscopic liver resection (LLR) for patients with complex hepatobiliary diseases.
- Patients using the 3D model experienced significantly fewer complications, including lower rates of intraoperative blood loss and bile leakage, compared to those who relied on traditional imaging.
- The findings suggest that 3D models are beneficial in reducing postoperative complications and can serve as a protective factor in surgical planning.
Background: Post-hepatectomy liver failure (PHLF) is a serious complication after hepatectomy and a major cause of death. The current criteria for PHLF diagnosis (ISGLS consensus) require laboratory data of elevated INR level and hyperbilirubinemia on or after postoperative day 5. This study aims to propose a new indicator for the early clinical prediction of PHLF.
View Article and Find Full Text PDFBackground: Platelet distribution width (PDW), but not platelet count, was found to more comprehensively reflect platelet activity. The present study, thus, aimed to evaluate the prognostic value of PDW to lymphocyte ratio (PDWLR) in patients with hepatocellular carcinoma (HCC) following hepatectomy.
Methods: Patients following hepatectomy were analyzed retrospectively.
Naples Prognostic Score is an Independent Prognostic Factor in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
J Hepatocell Carcinoma
September 2023
Background: Nutritional and inflammatory status has been reported to be associated with the prognosis of hepatocellular carcinoma (HCC), but many studies did not include all biomarkers simultaneously. The present study aimed to determine the impact of Naples prognostic score (NPS) on the long-term survival in patients undergoing hepatectomy for HCC.
Methods: Patients with HCC after curative resection were eligible.
Background And Aims: An increasing number of studies have confirmed that non-textbook outcomes (non-TO) are a risk factor for the long-term outcome of malignant tumors. It is particularly important to identify the predictive factors of non-TO to improve the quality of surgical treatment. We attempted to construct two nomograms for preoperative and postoperative prediction of non-TO after laparoscopic hepatectomy for hepatocellular carcinoma (HCC).
View Article and Find Full Text PDFSurvival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy.
Expert Rev Gastroenterol Hepatol
April 2023
Background & Aims: Although anatomical hepatectomy (AH) is widely used in the treatment of hepatocellular carcinoma (HCC), the prognosis is still unsatisfactory. The present study aimed to evaluate the survival benefit of adjuvant transcatheter arterial chemoembolization (TACE) for patients with HCC after AH.
Methods: A total of 832 patients were stratified into with adjuvant TACE (443, 53.